Correlation Between Takeda Pharmaceutical and Boston Properties

Can any of the company-specific risk be diversified away by investing in both Takeda Pharmaceutical and Boston Properties at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Takeda Pharmaceutical and Boston Properties into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Takeda Pharmaceutical and Boston Properties, you can compare the effects of market volatilities on Takeda Pharmaceutical and Boston Properties and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Takeda Pharmaceutical with a short position of Boston Properties. Check out your portfolio center. Please also check ongoing floating volatility patterns of Takeda Pharmaceutical and Boston Properties.

Diversification Opportunities for Takeda Pharmaceutical and Boston Properties

-0.7

Correlation Coefficient

Takeda Pharmaceutical  Boston Properties

Excellent diversification

The 3 months correlation between Takeda and Boston is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Takeda Pharmaceutical and Boston Properties in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Boston Properties and Takeda Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Takeda Pharmaceutical are associated (or correlated) with Boston Properties. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Boston Properties has no effect on the direction of Takeda Pharmaceutical i.e., Takeda Pharmaceutical and Boston Properties go up and down completely randomly.

Pair Corralation between Takeda Pharmaceutical and Boston Properties

Assuming the 90 days trading horizon Takeda Pharmaceutical is expected to under-perform the Boston Properties. But the stock apears to be less risky and, when comparing its historical volatility, Takeda Pharmaceutical is 1.24 times less risky than Boston Properties. The stock trades about 0.0 of its potential returns per unit of risk. The Boston Properties is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest  6,633  in Boston Properties on September 5, 2024 and sell it today you would earn a total of  1,045  from holding Boston Properties or generate 15.75% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	96.88%
Values	Daily Returns

Takeda Pharmaceutical  vs.  Boston Properties

Takeda Pharmaceutical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Takeda Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Takeda Pharmaceutical is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Boston Properties

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Boston Properties are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Boston Properties reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Takeda Pharmaceutical and Boston Properties

The main advantage of trading using opposite Takeda Pharmaceutical and Boston Properties positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Takeda Pharmaceutical position performs unexpectedly, Boston Properties can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Boston Properties will offset losses from the drop in Boston Properties' long position.

The idea behind Takeda Pharmaceutical and Boston Properties pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.